Linden Advisors’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Linden Advisors’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-178,701	Closed	-$1.78M	–	692
2022 Q3	$1.78M	Hold	178,701	–	–	0.02%	351
2022 Q2	$1.76M	Hold	178,701	–	–	0.02%	378
2022 Q1	$1.76M	Hold	178,701	–	–	0.01%	459
2021 Q4	$1.74M	Hold	178,701	–	–	0.01%	453
2021 Q3	$1.75M	Sell	178,701 -3,480	-2%	-$34K	0.01%	393
2021 Q2	$1.78M	Sell	182,181 -6,500	-3%	-$64.1K	0.01%	450
2021 Q1	$1.88M	Buy	+188,681	New	+$1.93M	0.01%	450

Linden Advisors's FLAC Position: Q4 2022 in Review

Linden Advisors sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 178,701 shares — an estimated $1.78M sold.

Linden Advisors first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.88M in Q1 2021. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

Linden Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
Linden Advisors sold 178,701 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $1.78M.
Linden Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
Linden Advisors's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $1.88M in Q1 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.